Primary Record
DICLAZURIL
- In stock
- 4,474 g
- Purity
- 99.0 %
- CAS
- 101831-37-2
Compound Identifiers & Properties
- CAS
- 101831-37-2
- PubChem CID
- 456389
- SMILES
- C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)Cl
- Canonical SMILES
- N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl
Names & Synonyms
- DICLAZURIL
- Clinacox
- Vecoxan
- Nuoqiu
- 101831-37-2
- Diclazurilo
- Diclazurilum
- null
- Protazil
- Coxiril
- Diclazuril CRS
- DCZL
- Diclazurilum [Latin]
- Diclazurilo [Spanish]
- Clinacox 0.2%
- Diclazuril (Standard)
- Diclazuril for veterinary use
- C17H9Cl3N4O2
- DICLAZURIL [MI]
- RefChem:55000
- Diclazuril (USP/INN)
- AC1L9UTR
- DICLAZURIL [INN]
- DICLAZURIL [USAN]
- K110K1B1VE
- UNII-K110K1B1VE
- DTXSID4046787
- DICLAZURIL [MART.]
- DICLAZURIL [USP-RS]
- MFCD00867203
- DTXCID2026787
- Diclazuril [USAN:BAN:INN]
- Diclazuril [USAN:INN:BAN]
- NSC-759642
- SCHEMBL126138
- ZSZFUDFOPOMEET-UHFFFAOYSA-N
- CHEMBL284733
- Diclazuril [USAN:USP:INN:BAN]
- orb1309527
- DICLAZURIL [GREEN BOOK]
- DRG-0079
- SCHEMBL27803573
- CHEBI:95118
- Diclazuril for system suitability
- HY-B0357R
- MSK7105
- DICLAZURIL [USP MONOGRAPH]
- GLXC-10872
- HMS2089N18
- HMS3655D11
- HMS3715D21
- HMS5080D17
- Pharmakon1600-01502348
- C17-H9-Cl3-N4-O2
- MSK7105-100AF
- AMY40398
- BCP12257
- HY-B0357
- MSK7105-1000AF
- R-64433
- R64,433
- Tox21_112645
- BDBM50088493
- CID456389
- DL-164
- NCGC00168785-01
- NP2642
- NSC759642
- s2028
- STL135982
- Diclazuril for system suitability CRS
- AKOS005746928
- P-64433
- CCG-213044
- CS-2411
- CS-O-01281
- DB11398
- Diclazuril, 98% - 100MG 100mg
- EBC-656268
- KS-5064
- NSC 759642
- SB18820
- NCGC00168785-02
- NCGC00168785-03
- NCGC00168785-09
- AC-12108
- AC-32608
- AN-34253
- BC204051
- SC-13717
- SY067418
- 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile
- R-64-433
- AB0105674
- AB2000434
- J413.493A
- CAS-101831-37-2
- D5457
- NS00000688
- SW199606-2
- D03794
- Diclazuril, VETRANAL(TM), analytical standard
- T70016
- 2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)acetonitrile
- AB01562968_01
- AB01562968_02
- Benzeneacetonitrile, 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-
- 831D372
- A800467
- P 64433
- R 64433
- SR-05000001484
- DICLAZURIL FOR VETERINARY USE [EP MONOGRAPH]
- Diclazuril Solution in Acetonitrile/DMF, 1000ug/mL
- Diclazuril Solution in Acetonitrile/DMF, 100ug/mL
- I01-0373
- Q5273856
- SR-05000001484-1
- SR-05000001484-2
- BRD-A06426627-001-03-5
- BRD-A06426627-001-04-3
- (p-Chlorophenyl)(2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl)acetonitrile
- 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile
- Diclazuril, United States Pharmacopeia (USP) Reference Standard
- 2-[4-(4-chloro-alpha-cyanobenzyl)-3,5-dichlorophenyl]-1,2,4-triazine-3,5(2H,4H)-dione
- (4-chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile
- DCL
- 2-[3,5-Dichloro-4-(alpha-cyano-4-chlorobenzyl)phenyl]-1,2,4-triazine-3,5(2H,4H)-dione
- Diclazuril for system suitability, European Pharmacopoeia (EP) Reference Standard
- (p-chlorophenyl)[2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl]acetonitrile
- (RS)-(4-Chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile
- 2,6-Dichloro-.alpha.-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile
- 2,6-Dichloro-|_-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile
- 2,6-Dichloro-|A-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile
- 2,6-Dichloro-|A-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl]benzeneacetonitrile
- 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile
- 2,6-Dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benz-eneacetonitrile
- 2,6-dichloro-alpha-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl]benzeneacetonitr
- 2,6-Dichloro-alpha-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl]benzeneacetonitrile
- 2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)phenyl)acetonitrile
- 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)phenyl]acetonitrile
- 2-(4-Chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile
- 4-chlorophenyl (2,6-dichloro-4-(4,5-dihydro-3H-3,5-dioxo-1,2,4-triazin-2-yl)pheny l) acetonitrile
- BENZENEACETONITRILE, 2,6-DICHLORO-.ALPHA.-(4-CHLOROPHENYL)-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN-2(3H)-YL)-
- Benzeneacetonitrile, 2,6-dichloro-|A-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-
- Diclazuril; (RS)-(4-Chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile; Benzeneacetonitrile, 2,6-dichloro-a-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-; 2,6-Dichloro-a-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; Clinacox; Diclazuril; Nuoqiu; P 64433; R 64433; Vecoxan